Best Agrolife Limited reported a significant decline in financial performance for the financial year ended March 31, 2026, with annual net profit falling 87% to ₹9 crore from ₹70 crore in the previous year. Revenue from operations dropped 31% to ₹1,257 crore compared to ₹1,814 crore in FY25. The company posted a net loss of ₹37 crore in Q4 FY26, compared to a net loss of ₹22 crore in Q4 FY25, while quarterly revenue stood at ₹156 crore, sharply lower than ₹274 crore recorded in the corresponding period last year. The Board of Directors recommended a final dividend of ₹0.10 per equity share for FY26.

Management Commentary and Strategic Outlook

Mr. Vimal Kumar, Managing Director, attributed the Q4 performance to a sharp increase in raw material prices due to the Gulf conflict. The company strategically curtailed sales in March across B2B and B2C segments to avoid lower realization sales, impacting potential revenues of approximately ₹50–70 crore. To mitigate rising input costs, the company implemented two rounds of price increases in early April and May 2026. Despite the challenges, the company reduced OPEX by 15% year-on-year to ₹280 crore and decreased inventory levels from ₹773 crore in FY25 to ₹651 crore as of March 31, 2026.

Operational Highlights

During FY26, the company expanded its specialty portfolio with the launch of three patented formulations: Bestman™, Fetagen™, and Shot Down™. It strengthened its intellectual property with the grant of seven patents, including a patented Nano Urea. The company plans to launch four additional patented products in FY27: Fluzam™, Midcotin™, Cubax Power Extra™, and Trishanku™. Branded sales accounted for 63% of total sales in FY26, with patented products contributing 41% to branded sales.

Financial Performance

The following table summarises the key financial metrics for the quarter and year:

Board Decisions and Auditor's Report

The Board of Directors, in its meeting held on May 27, 2026, approved the audited financial results and recommended a final dividend of ₹0.10 per equity share for FY26. M/s Walker Chandiok & Co LLP, Statutory Auditor, issued an un-modified opinion but included an emphasis of matter regarding a search operation by the Income Tax Department in September 2023 and a subsequent demand order for ₹0.95 crore for assessment year 2021-22.

Best Agrolife Limited has submitted its Monitoring Agency Report for the quarter ended March 31, 2026, to the BSE and the National Stock Exchange of India on May 07, 2026, in compliance with Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 162A(4) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The report was prepared by Crisil Ratings Limited, the appointed Monitoring Agency, and pertains to the utilization of proceeds raised through a preferential issue of convertible warrants. The company, classified under the Pesticides & Agrochemicals sector, has its registered and corporate office at B-4, Bhagwan Dass Nagar, East Punjabi Bagh, New Delhi-110026.

Issue Background and Revised Proceeds

The preferential issue was open from December 17, 2024, to December 26, 2024, with an original issue size of Rs 200.00 crore. However, due to undersubscription of warrants — arising from non-receipt of the warrant subscription price equivalent to 25% of the Warrants Issue Price — the board of directors, via a resolution dated December 27, 2024, revised the issue size downward to Rs 150.00 crore. The revised allocation of proceeds across the stated objects is detailed below:

Utilization Status for Quarter Ended March 31, 2026

As of the quarter ended March 31, 2025, the company had received Rs 37.50 crore, representing 25% of the revised issue size, as the initial subscription amount. No additional amounts were received or utilized during the quarter ended March 31, 2026. The progress in utilization of the revised issue proceeds is summarized below:

The Monitoring Agency noted no utilization during the reported quarter across all three heads. The balance amount of Rs 112.50 crore is yet to be received from warrant holders. As per the notice to shareholders dated September 06, 2024, warrant holders have the option to convert the warrants into equity shares within 18 months from the date of allotment, i.e., December 27, 2024.

Deployment of Unutilised Proceeds

Based on the management undertaking and a certificate dated April 28, 2026, issued by M/S TATTVAM & Co, Chartered Accountants (Firm Registration Number: 015048N), the unutilised proceeds held in the Preferential Issue account of the company at Indian Bank (Account No. 7867851503) stood at Nil as of March 31, 2026, with no earnings or return on investment recorded for the quarter.

Key Risk: Warrant Exercise Price vs. Market Price

The Monitoring Agency flagged an unfavorable development relevant to investors. The company completed a stock split, reducing the face value of equity shares from Rs 10 each to Rs 1 each, and also executed a bonus issue in the ratio of 1:2 to existing shareholders. Following the stock split, the warrant exercise price was proportionately revised to Rs 64.00 per share, and bonus shares reserved for warrant holders are to be allotted upon exercise of conversion rights, subject to applicable laws.

As on May 04, 2026, the equity shares of the company were trading at approximately Rs 17.75 per share, significantly below the revised exercise price of Rs 64.00 per share. The Monitoring Agency highlighted that this disparity presents an inherent risk of non-exercise of conversion rights, which may impact the realization of the remaining proceeds from the warrants.

Compliance and Certifications

No deviation from the objects of the issue was observed, and no change in the means of finance was reported. The Monitoring Agency confirmed no major deviation over earlier reports. The report was prepared in accordance with Schedule XI of the SEBI ICDR Regulations and is supported by a peer-reviewed Independent Chartered Accountant Certificate dated April 28, 2026, from M/S TATTVAM & Co. The report has been signed by Shounak Chakravarty, Director, Ratings (LCG), Crisil Ratings Limited, and the submission to the exchanges was made by Aarti Arora, CS & Compliance Officer of Best Agrolife Limited. The report is also available on the company's website at www.bestagrolife.com .